eScholarship
metadata only
CC BY-NC-ND
RNA therapy: Are we using the right molecules?
Small-molecule and protein/antibody drugs mainly act on genome-derived proteins to exert pharmacological effects. RNA based therapies hold the promise to expand the range of druggable targets from proteins to RNAs and the genome, as evidenced by several RNA drugs approved for clinical practice and m
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges#1263500
- Target, silence, replace: a review on RNA-based drugs in modern medicine.#975612
- Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides.#135931
- Physiological roles of small RNA molecules#124259
- Machine learning for RNA-targeting drug design#1122986
Record · ID 1311312
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive